STK11/KEAP1 co-mutations lead to a notable increase in the expression of ferroptosis-protective genes, including SCD and AKR1C1/2/3, as well as resistance to drug-induced ferroptosis in lung cancer cells [26]. This evidence concerns the gene STK11 and lung carcinoma.